Sanders to Biden: Cut back looming Medicare premium hike

Dec 3, 2021, 11:05 AM | Updated: Dec 4, 2021, 4:51 pm

WASHINGTON (AP) — Sen. Bernie Sanders is asking the White House to cut back a big Medicare premium hike set to take effect in weeks and tied to a pricey Alzheimer’s drug whose benefits have been widely questioned.

In a letter Friday to President Joe Biden, the Vermont Independent called on the president to act immediately to prevent the portion of an “outrageous increase” in Medicare premiums that’s attributable to Aduhelm, a newly approved Alzheimer’s medicine from drugmaker Biogen, priced at $56,000 a year.

If Biden agreed and found a way to do it, a planned January increase of $21.60 a month to Medicare’s “Part B” premium for outpatient care would be slashed closer to $10. The monthly premium for 2022 would drop from $170.10 to about $159.

Biden’s massive social agenda legislation takes significant steps to curb prescription drug costs, but Democrats are running the risk that seniors smarting from one of the biggest increases ever in Medicare premiums will turn against them in the 2022 midterm elections. That increase would claw back a big chunk of next year’s Social Security cost-of-living allowance, a boost of about $92 a month for the average retired worker, to help cover rising prices for gas and food.

“Biogen’s $56,000 price of Aduhelm is the poster child for how dysfunctional our prescription drug pricing system has become,” Sanders wrote to Biden. “The notion that one pharmaceutical company can raise the price of one drug so much that it could negatively impact 57 million senior citizens and the future of Medicare is beyond absurd. With Democrats in control of the White House, the House and the Senate we cannot let that happen.” A copy of the letter was provided to The Associated Press.

There was no immediate comment from the White House. Biden is planning a speech Monday on the prescription drug provisions of his legislation, including an annual cap of $2,000 on out-of-pocket costs for Medicare recipients, $35 monthly copays for insulin, inflation rebates that would also help people with private insurance, and the first-ever Medicare-negotiated prices. The catch is that those benefits will phase in over time and the Medicare premium hike would hit after the New Year. It’s not clear if Biden will address the premiums.

The boost in premiums “could not come at a worse time for older Americans all over this country who are struggling economically,” Sanders wrote.

The jump of $21.60 a month is the biggest increase ever for Medicare premiums in dollar terms, although not percentage-wise. As recently as August, the Medicare Trustees’ report had projected a smaller increase of $10 from the current $148.50. Medicare said it had to boost the rate higher to set aside a contingency fund in case the program formally approves coverage for Aduhelm.

Alzheimer’s is a progressive neurological disease with no known cure, affecting about 6 million Americans, the vast majority old enough to qualify for Medicare.

Aduhelm is the first Alzheimer’s medication in nearly 20 years, although it doesn’t cure the disease. The Food and Drug Administration approved the drug this summer, determining that Aduhelm’s ability to reduce clumps of plaque in the brain is likely to slow dementia. That decision was highly controversial, since the FDA overrode its own outside advisers. Many experts say Aduhelm’s benefit has not been clearly demonstrated. The Department of Veterans Affairs declined to list the medicine on its roster of approved drugs.

Medicare has begun a formal assessment to determine whether it should cover the drug, and a final decision isn’t likely until at least the spring. For now, Medicare is deciding on a case-by-case basis whether to pay for Aduhelm.

Sanders asked Biden to order Medicare to hold off on approving coverage of Aduhelm until there is scientific consensus about its benefits.

Biogen has defended its pricing, saying it looked carefully at costs of advanced medications to treat cancer and other conditions. A nonprofit think tank focused on drug pricing pegged Adulhelm’s actual value at between $3,000 and $8,400 per year — not $56,000 — based on its unproven benefits.

Copyright © The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

AP

Federal Reserve Board Chair Jerome Powell speaks during a news conference at the Federal Reserve, W...
Associated Press

Powell: Fed to keep hiking rates until it controls inflation

WASHINGTON (AP) — Chair Jerome Powell on Tuesday underscored the Federal Reserve’s determination to keep raising interest rates until there is clear evidence inflation is steadily falling — a high-stakes effort that carries the risk of causing an eventual recession. The Fed’s increases in its benchmark short-term rate typically lead, in turn, to higher borrowing […]
17 hours ago
Associated Press

N. Korea reports another jump in suspected COVID-19 cases

SEOUL, South Korea (AP) — North Korea on Wednesday reported 232,880 new cases of fever and another six deaths as leader Kim Jong Un accused officials of “immaturity” and “slackness” in handling the escalating COVID-19 outbreak ravaging across the unvaccinated nation. The country’s anti-virus headquarters said 62 people have died and more than 1.7 million […]
17 hours ago
Associated Press

Deer District shootings leave Milwaukee leaders at the brink

Milwaukee’s mayor and police chief on Tuesday pleaded with citizens and lawmakers to help address ongoing gun violence punctuated by shootings outside an NBA playoff game that left 21 injured. Police Chief Jeffrey Norman said police have arrested 11 people varying in ages from 19 to 30 for the Friday night incidents near a downtown […]
17 hours ago
FILE - Bill Cosby arrives for a sentencing hearing following his sexual assault conviction at the M...
Associated Press

Bill Cosby lawyers cry foul as civil sex assault trial looms

SANTA MONICA, Calif. (AP) — With jury selection less than a week away, attorneys scrambled to deal with shifting evidence Tuesday in Bill Cosby’s civil trial over allegations that he sexually assaulted a teenage girl at the Playboy mansion nearly 50 years ago. Plaintiff Judy Huth said in a recent court filing that she now […]
17 hours ago
This image released by ABC shows Nathan Fillion, left, and Niecy Nash-Betts in a scene from "The Ro...
Associated Press

Nielsen list illustrates power of franchises for networks

NEW YORK (AP) — With the broadcast television season winding down and most scripted series about to go into hibernation for the summer, it’s instructive to look at the power of network franchises. Of the Nielsen company’s 20 most popular scripted series on the air last week, 12 were parts of franchises — the three […]
17 hours ago
Follow @ktar923...
Sponsored Content by Barrow Neurological Institute

Stroke month: Experts call attention to stroke prevention

Every 40 seconds—that’s how often someone has a stroke in the United States. It’s the fifth leading cause of death among Americans, with someone dying of a stroke every 3.5 minutes.

Sponsored Articles

...
By Dr. Richard Carmona

Now’s a great time to receive your COVID-19 vaccine

If you haven’t received a COVID-19 vaccine yet, now’s the time to join many other of your fellow Arizonans who are doing so right now. No one will criticize you; there is no shame. In fact, you’ll be welcomed with smiles and open arms!
...
SCHWARTZ LASER EYE CENTER

Key dates for Arizona sports fans to look forward to in April

April brings new beginnings in different ways for Arizona’s professional sports teams like the Suns and Diamondbacks.
...
Dr. Richard Carmona

COVID-19 shots continue long tradition of vaccines protecting public health

You want to feel safe. You want your family to be safe. Are vaccines safe? The simple and important answer is: Oh my yes!
Sanders to Biden: Cut back looming Medicare premium hike